Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 4, 2008 - Issue 2
Submit an article Journal homepage
62
Views
9
CrossRef citations to date
0
Altmetric
Expert Opinion

Review of the clinical evidence for interferon β 1a (Rebif®) in the treatment of multiple sclerosis

Francesco Manfredonia1 Department of Neuroscience, University of PisaPisa, Italy
,
Livia Pasquali1 Department of Neuroscience, University of PisaPisa, Italy
,
Angela Dardano2 Department of Internal Medicine, University of PisaPisa, Italy
,
Alfonso Iudice1 Department of Neuroscience, University of PisaPisa, Italy
,
Luigi Murri1 Department of Neuroscience, University of PisaPisa, Italy
&
Fabio Monzani2 Department of Internal Medicine, University of PisaPisa, ItalyCorrespondence[email protected]
Pages 321-336 | Published online: 11 Apr 2008

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Mika Scheinin, Zsófia Lovró, Inger-Helen Maadik, Jaana Suopanki-Lalowski, Seyed Hossein Seyedagha & Morteza Azhdarzadeh. (2022) A randomized pharmacokinetic-pharmacodynamic evaluation of the potential biosimilar interferon beta-1a product, CinnoVex®. Expert Opinion on Biological Therapy 22:2, pages 169-178.
Read now
William C. Lamanna, Johann Holzmann, Hillel P. Cohen, Xinghua Guo, Monika Schweigler, Thomas Stangler, Andreas Seidl & Martin Schiestl. (2018) Maintaining consistent quality and clinical performance of biopharmaceuticals. Expert Opinion on Biological Therapy 18:4, pages 369-379.
Read now
Nikolaos Grigoriadis, Michael Linnebank, Nektaria Alexandri, Sarah Muehl & Günther F. L. Hofbauer. (2016) Considerations on long-term immuno-intervention in the treatment of multiple sclerosis: an expert opinion. Expert Opinion on Pharmacotherapy 17:15, pages 2085-2095.
Read now
Alessandra Lugaresi, Maria di Ioia, Daniela Travaglini, Erika Pietrolongo, Eugenio Pucci & Marco Onofrj. (2013) Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis. Neuropsychiatric Disease and Treatment 9, pages 893-914.
Read now
Denise C Fitzgerald & Abdolmohamad Rostami. (2009) Therapeutic potential of IL-27 in multiple sclerosis?. Expert Opinion on Biological Therapy 9:2, pages 149-160.
Read now

Articles from other publishers (4)

Sabbir Khan, Rajasekaran Mahalingam, Shayak Sen, Emmanuel Martinez-Ledesma, Arshad Khan, Kaitlin Gandy, Frederick F. Lang, Erik P. Sulman, Kristin D. Alfaro-Munoz, Nazanin K. Majd, Veerakumar Balasubramaniyan & John F. de Groot. (2021) Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells. Cancers 13:21, pages 5284.
Crossref
Francesco Pappalardo, Giulia Russo, Marzio Pennisi, Giuseppe Alessandro Parasiliti Palumbo, Giuseppe Sgroi, Santo Motta & Davide Maimone. (2020) The Potential of Computational Modeling to Predict Disease Course and Treatment Response in Patients with Relapsing Multiple Sclerosis. Cells 9:3, pages 586.
Crossref
Francesco Pappalardo, Giulia Russo, Marzio Pennisi, Giuseppe Sgroi, Giuseppe Alessandro Parasiliti Palumbo, Santo Motta, Davide Maimone & Ferdinando Chiacchio. (2018) Agent based modeling of relapsing multiple sclerosis: a possible approach to predict treatment outcome. Agent based modeling of relapsing multiple sclerosis: a possible approach to predict treatment outcome.
Cynthia Louis, Chris Burns & Ian Wicks. (2018) TANK-Binding Kinase 1-Dependent Responses in Health and Autoimmunity. Frontiers in Immunology 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.